Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study.
Parisi S, Becciolini A, Ditto MC, Rozza D, Zanetti A, Laganà A, Peroni CL, Centanaro Di Vittorio C, Degiovanni R, Realmuto C, Scirè CA, Priora M, Di Donato E, Santilli D, Mozzani F, Lucchini G, Ariani A, Gardelli L, Girelli F, Arrigoni E, Platè I, Bravi E, Paroli M, Caccavale R, Salvarani C, Sandri G, Lumetti F, Volpe A, Marchetta A, Fusaro E. Parisi S, et al. Among authors: becciolini a. J Clin Med. 2022 Jan 26;11(3):621. doi: 10.3390/jcm11030621. J Clin Med. 2022. PMID: 35160074 Free PMC article.
Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry.
Favalli EG, Sinigaglia L, Becciolini A, Grosso V, Gorla R, Bazzani C, Atzeni F, Sarzi Puttini PC, Fusaro E, Pellerito R, Caporali R. Favalli EG, et al. Among authors: becciolini a. Int J Rheum Dis. 2018 Feb;21(2):422-430. doi: 10.1111/1756-185X.13199. Epub 2017 Oct 30. Int J Rheum Dis. 2018. PMID: 29082659
Efficacy and retention rate of adalimumab in rheumatoid arthritis and psoriatic arthritis patients after first-line etanercept failure: the FEARLESS cohort.
Favalli EG, Becciolini A, Carletto A, Conti F, Amato G, Fusaro E, Quartuccio L, Egan CG, Lo Monaco A, Benucci M, Salaffi F, Semeraro A, Parisi S, Ceccarelli F, Piazza I, Foti R. Favalli EG, et al. Among authors: becciolini a. Rheumatol Int. 2020 Feb;40(2):263-272. doi: 10.1007/s00296-019-04416-3. Epub 2019 Aug 21. Rheumatol Int. 2020. PMID: 31435754
bDMARDs retention rate in the biosimilar era: A real-life monocentric study.
Becciolini A, Lumetti F, Donato ED, Giordano S, Santilli D, Mozzani F, Riva M, Lucchini G, Ariani A. Becciolini A, et al. Eur J Rheumatol. 2021 Apr;8(2):109-110. doi: 10.5152/eurjrheum.2020.20080. Eur J Rheumatol. 2021. PMID: 32910769 Free PMC article. No abstract available.
A Parsonage-Turner Syndrome secondary to Parvovirus B19 infection.
Mozzani F, Marino NG, Becciolini A, Di Donato E, Ariani A, Santilli D. Mozzani F, et al. Among authors: becciolini a. Acta Biomed. 2021 Apr 30;92(S1):e2021129. doi: 10.23750/abm.v92iS1.10702. Acta Biomed. 2021. PMID: 33944819 Free PMC article.
Internal medicine inpatients' prevalence of misdiagnosed severe osteoporosis.
Casella M, Becciolini A, Di Donato E, Basaglia M, Zardo M, Lucchini G, Riva M, Ariani A, Magalini F. Casella M, et al. Among authors: becciolini a. Osteoporos Int. 2021 Nov;32(11):2361-2364. doi: 10.1007/s00198-021-05976-6. Epub 2021 May 5. Osteoporos Int. 2021. PMID: 33950266
148 results